Simplified characterization of pseudorabies viruses using monoclonal antibody and selective cell culture analyses
Jonathan Bruce Katz, John George Landgraf All modified-live pseudorabies virus (PRV) vaccines (V-PRV) used in the United States today contain glycoprotein gI (gI) gene deletions and/or deletions in the thymidine kinase (TK) gene (Table 1) . 1, 5, 6, 9, 10 Typically, wild type pseudorabies viruses (WT-PRV) are both gI and TK positive. 1, 5, 9, 10 Companion diagnostic glycoprotein-specific enzyme-linked immunosorbent assay (ELISA) systems are available; these allow serologic differentiation between swine vaccinated with V-PRV and those exposed to WT-PRV. 5, 6, 10 Definitive diagnostic differentiation between V-PRV and WT-PRV viruses themselves is, however, a complex process involving restriction endonuclease analysis (REA), Southern blotting with gene-specific DNA probes, and Western blotting with glycoprotein-specific antibodies. 1, 3 Differentiating between V-PRV and WT-PRV isolates is important for herd health and for regulatory and forensic purposes. Differentiation is also useful in epidemiologic studies and studies on viral latency and recrudescence and for evaluating the environmental behavior of vaccine viruses. 3, 4, 6 We have developed a simple strategy to determine which isolates are typical WT-PRV and which cannot possibly be so, including atypical WT-PRV , V-PRV, and V-PRV that may have been environmentally altered with respect to their gI or TK phenotypes. By grouping PRV isolates in this manner, authentic V-PRV, altered V-PRV, and atypical WT-PRV can be identified for more detailed differential diagnosis.
Because all V-PRV are gI negative (gI -), TK negative (TK -), or both gIand TK -, isolates that are gI and TK positive (gI + , TK + ) cannot be V-PRV. Isolates that are (gIand TK -), (gIand TK + ), and (gI + and TK -) could theoretically be V-PRV, atypical WT-PRV, or V-PRV/WT-PRV recombinants. 2, 5 Determination of TK phenotype has been previously described. 4, 5 A sample of 10 4 -10 6 plaque forming units (PFU) of each isolate was serially passaged 4 times at 2-3-day intervals in a TK mouse connective tissue cell line f (LMTK -, American Type Culture Collection Certified Cell Line 1.3) in the presence of methotrexate. g TK + viruses propagated normally in these cells, but TKviruses were selectively unable to do so. Reference TK + and TK -PRVs were used as procedural controls. Following serial passage, culture supernatants were titrated for the presence of PRV in Madin Darby bovine kidney (MDBK) cells. 4 TK + viruses maintained viral titer, but TKviruses were completely eliminated (0 PFU/ 0.1 m1). 4,5 TKresults were always reconfirmed. Viral gI status was routinely assessed by examining 50-200 viral plaques in infected MDBK cell monolayers using 2 gI-specific but epitopically noncompetitive monoclonal antibodies h,7 (MAbs) in an indirect fluorescent antibody test (IFAT) format. Both of these MAbs (7-3 and 8-2) were used separately on each isolate to improve the probability of detecting gI expression. Other gI-specific MAbs i,j were also found acceptable for assessment of gI status.
Ninety-five diagnostic isolates were examined using the TK and gI tests (81 porcine, 8 bovine, 4 ovine, 2 canine). Three reference WT-PRV isolates and all US licensed V-PRVs were also evaluated ( Table 2 ). Among the diagnostic isolates, 88 were TK + and gI + , 5 were TK + and gI -, 1 was TKand gI -, and 1 was TK + and gI +/-(MAb 7-3 + , MAb 8-2 -). Isolate Nos. 1-88 were classified as typical WT-PRV. Isolate Nos. 90-94 (TK + , gI -) were determined by REA as different from either of the 2 TK + , gI -V-PRV vaccine strains, indicating that they were either of atypical WT-PRV or al- Table 2 . Thymidine kinase (TK) and glycoprotein I (gI) classification of 95 diagnostic pseudorabies virus (PRV) isolates and PRV vaccine reference strains. tered V-PRV origin. The 2 atypical porcine isolates (Nos. 93, 94) differed by REA from each other and from the 3 atypical bovine isolates (Nos. 90-92). Isolate Nos. 90, 91, and 92 originated from the same Iowa cattle herd and had REA patterns indistinguishable from each other and from another atypical bovine isolate, No. 89 (TK -, gI -), which originated from Illinois (Fig. 1) .
Isolate Nos. 90-92 were not eliminated by serial propagation in LMTKcells but were reduced in titer to approximately 10 2 PFU/0.1 ml. In contrast, reference TK + viruses and isolate Nos. 1-88 titered 10 4 -10 6 PFU/0.1 ml. Isolate Nos. 90-92 were doubly plaque purified, each in quadruplicate, and the resulting 12 viruses reconfirmed phenotypically with uniform results.
Isolate No. 95 was TK + and repeatedly IFAT positive with MAb 7-3 but negative with MAb 8-2. No V-PRV shares this profile (Tables 1, 2). A 27-kg PRV-seronegative pig inoculated intranasally with 10 2.5 PFU of isolate No. 95 developed severe clinical signs of PRV infection 5 days postinoculation (PI). Using a commercial gI-specific diagnostic ELISA test, k,7 gI + seroconversion was detected 9 days PI and confirmed 19 days PI, indicating that isolate No. 95 was a virulent but atypical WT-PRV and that its degree of gI alteration did not preclude correct gI-specific serologic diagnosis.
The TK-selective cell culture/gI IFAT analytic system correctly classified all US-licensed PRV vaccines as V-PRV. The great majority of current field isolates were TK + and gI + . The minority with atypical TK and/or gI phenotypes must be studied further to differentiate them into unaltered V-PRV, potentially altered V-PRV, and atypical WT-PRV categories. 1 The possibility of multiple strains in an isolate must be considered, and multiple analyses of plaque-purified isolates may be necessary if strain heterogeneity is suspected. No unaltered V-PRV was found in this study.
Bovine herpesvirus 1 modified-live vaccines have under-gone REA pattern alterations following only 1 passage through the host species. 11 Some of the atypical WT-PRV identified in this study may have arisen in a similar manner. The similarities between the REA pattern of No. 89 and those of Nos. 90-92 suggests a possible iatrogenic V-PRV origin for these viruses. There is 1 report from Germany of a bovine origin PRV isolate with a pattern of split MAb reactivity similar to that found with isolate No. 95. 8 In that study, the molecular basis of the unusual MAb reactivity was associated with a truncated form of gI. 8 The simple phenotypic screening system described here will help identify those unusual isolates requiring further study to determine their possible origins and veterinary diagnostic significance. The use of a particular manufacturer's product does not constitute an endorsement on behalf of the USDA.
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